Systemic inflammation can induce systemic hypercoagulability, and many inflammatory chemokines such as for tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and IL-6, are involved in the formation of thromboses. This evidence concerns the gene TNF and thrombotic disease.